One of the UK’s leading aesthetic doctors Beatriz Molina has conducted the first ever global study into patient satisfaction with a cosmetic procedure.
The medical doctor who runs Medikas Bristol and Somerset, travels the world lecturing and talking about best practice in aesthetics.
She’s now published her first research into how patients feel about the results of a cosmetic procedure – in this case, botox injections into frown lines on the forehead between the eyebrows – known as the glabellar lines. Her study has just been published in the Aesthetics Journal.
Dr Molina said: “We talk about patient satisfaction and making a difference to patients’ lives at conferences and meetings across the globe.
“But measuring satisfaction in quantifiable terms is difficult. How is it possible to measure what kind of difference you make to a patient’s life with the procedure you administer?
“This was the thinking behind the ANGEL study which was a non-interventional observational initiative carried out in France, Germany, Spain and the UK.”
The project – ‘Patient Satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study’– looked at the relationship between treatment with botulinum toxin type A and patient satisfaction. It’s the first study of its kind.
Sixty-six clinics recruited 559 patients between the ages of 18 and 64 years old, with moderate or severe glabellar lines and were eligible only if the investigator had already decided to prescribe this as the correct treatment for them.
No one was paid to complete the study which lasted for four months. Patients were asked to complete two questionnaires at three weeks and four months following the first injection. Of those 559, 531 (95.0%) completed the questionnaire at week three and 485 (86.8%) at month four.
Of those who originally enrolled, 93.4% and 88.7% considered their results ‘surpassed’ or ‘met’ their expectations at week three and month four, respectively.
Satisfaction and reaction to the treatment did not revolve primarily around ‘beauty’ following the procedure. The main reasons given for satisfaction were a natural appearance, a rested look and comfort of injection.
Dr Molina said: “We’ve long understood cosmetic medicine can support a patient’s general well-being and I believe it’s crucial we conduct more formal studies like this to aid our understanding of patient satisfaction.
“I also believe this shows the importance of psychological training within the structure of aesthetics and medical training.
“Exposing medical students to psychological practice and concepts is crucial to ensure only suitable patients who are sound of judgement receive aesthetic treatment.”
Dr Molina hopes to carry out a further study during 2015 on a cosmetic treatment on lines around the mouth.
One of the UK’s leading aesthetic doctors Beatriz Molina has conducted the first ever global study into patient satisfaction with a cosmetic procedure.
The medical doctor who runs Medikas Bristol and Somerset, travels the world lecturing and talking about best practice in aesthetics.
She’s now published her first research into how patients feel about the results of a cosmetic procedure – in this case, botox injections into frown lines on the forehead between the eyebrows – known as the glabellar lines. Her study has just been published in the Aesthetics Journal.
Dr Molina said: “We talk about patient satisfaction and making a difference to patients’ lives at conferences and meetings across the globe.
“But measuring satisfaction in quantifiable terms is difficult. How is it possible to measure what kind of difference you make to a patient’s life with the procedure you administer?
“This was the thinking behind the ANGEL study which was a non-interventional observational initiative carried out in France, Germany, Spain and the UK.”
The project – ‘Patient Satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study’– looked at the relationship between treatment with botulinum toxin type A and patient satisfaction. It’s the first study of its kind.
Sixty-six clinics recruited 559 patients between the ages of 18 and 64 years old, with moderate or severe glabellar lines and were eligible only if the investigator had already decided to prescribe this as the correct treatment for them.
No one was paid to complete the study which lasted for four months. Patients were asked to complete two questionnaires at three weeks and four months following the first injection. Of those 559, 531 (95.0%) completed the questionnaire at week three and 485 (86.8%) at month four.
Of those who originally enrolled, 93.4% and 88.7% considered their results ‘surpassed’ or ‘met’ their expectations at week three and month four, respectively.
Satisfaction and reaction to the treatment did not revolve primarily around ‘beauty’ following the procedure. The main reasons given for satisfaction were a natural appearance, a rested look and comfort of injection.
Dr Molina said: “We’ve long understood cosmetic medicine can support a patient’s general well-being and I believe it’s crucial we conduct more formal studies like this to aid our understanding of patient satisfaction.
“I also believe this shows the importance of psychological training within the structure of aesthetics and medical training.
“Exposing medical students to psychological practice and concepts is crucial to ensure only suitable patients who are sound of judgement receive aesthetic treatment.”
Dr Molina hopes to carry out a further study during 2015 on a cosmetic treatment on lines around the mouth.